MBL2 and MASP2 gene polymorphisms in patients with hepatocellular carcinoma

L. Segat, A. Fabris, L. Padovan, M. Milanese, D. Pirulli, F. Lupo, M. Salizzoni, A. Amoroso, S. Crovella

Research output: Contribution to journalArticlepeer-review


The pathogenesis of hepatocellular carcinoma (HCC) is not fully understood, but the majority of patients with HCC are associated with hepatitis B virus (HBV) or hepatitis C virus (HCV) infection. Mannan-binding lectin (MBL) is a collectin that can act directly as opsonine or activate MBL-associated serine proteases (MASPs) thus initiating the antibody-independent pathway of the complement system. In our study, we analysed two MBL2 and MASP2 functional polymorphisms (MBL2 allele A/0 and MASP2 D120G) as well as MASP2 polymorphism (Y371D) responsible for an amino acidic change in the protein in 215 HCC patients (HBV-infected, HCV-infected, HBV/HCV co-infected and patients with HCC with no viral infection) and 164 healthy controls to give new insights regarding the role of these two molecules in HCC and viral infection pathogenesis. No significant association was found between MBL2 or MASP2 alleles or genotypes, neither comparing the total patients with HCC and healthy controls nor between the different groups of HCC subjects divided for type of viral infection. Also, dividing the total HCC patients group into low MBL producer (A0 and 00 genotypes) and normal producer (AA genotype) and comparing MASP2 polymorphisms in these two groups, no significant differences were found. Our data do not seem to suggest a role for MBL2 and MASP2 polymorphisms in HCC susceptibility either for HBV-HCV infection-dependent HCC or for HCC raised as a consequence of exposure to different risk factors.

Original languageEnglish
Pages (from-to)387-391
Number of pages5
JournalJournal of Viral Hepatitis
Issue number5
Publication statusPublished - May 2008


  • HBV
  • HCV
  • Hepatocellular carcinoma
  • MASP2
  • MBL2
  • Polymorphisms

ASJC Scopus subject areas

  • Virology
  • Hepatology


Dive into the research topics of 'MBL2 and MASP2 gene polymorphisms in patients with hepatocellular carcinoma'. Together they form a unique fingerprint.

Cite this